Alnylam Pharmaceuticals, Inc.
ALNY
$292.03
$7.192.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.32% | 7.94% | -2.00% | 8.87% | 11.00% |
| Total Receivables | 111.46% | 91.85% | 172.65% | 83.25% | 30.08% |
| Inventory | 28.12% | 5.36% | -0.79% | -14.64% | -30.22% |
| Prepaid Expenses | 58.84% | 141.01% | 29.37% | -4.80% | -24.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 29.10% | 22.92% | 17.80% | 14.84% | 9.36% |
|
|
|||||
| Total Current Assets | 29.10% | 22.92% | 17.80% | 14.84% | 9.36% |
| Net Property, Plant & Equipment | 1.67% | 2.04% | -1.46% | -3.25% | -3.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -18.81% | -17.21% | 40.69% | 89.69% | 113.64% |
| Total Assets | 21.73% | 17.13% | 15.38% | 13.88% | 10.18% |
|
|
|||||
| Total Accounts Payable | 30.01% | 30.88% | 66.08% | 38.41% | 24.63% |
| Total Accrued Expenses | 34.41% | 17.10% | 21.93% | 13.64% | 0.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 113.72% | 71.45% | 20.95% | 38.60% | 45.49% |
| Total Finance Division Other Current Liabilities | -97.80% | 9.16% | 74.28% | 96.88% | 90.31% |
| Total Other Current Liabilities | -97.80% | 9.16% | 74.28% | 96.88% | 90.31% |
| Total Current Liabilities | 25.46% | 23.61% | 27.43% | 23.27% | 14.22% |
|
|
|||||
| Total Current Liabilities | 25.46% | 23.61% | 27.43% | 23.27% | 14.22% |
| Long-Term Debt | 4.85% | 5.05% | 1.35% | 0.27% | 0.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.23% | -1.94% | -5.34% | -6.23% | -3.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.22% | -98.09% | 25.37% | 18.60% | -15.27% |
| Total Liabilities | -1.08% | 0.10% | 10.67% | 7.54% | 1.35% |
|
|
|||||
| Common Stock & APIC | 1.32% | 1.66% | 2.13% | 7.97% | 8.93% |
| Retained Earnings | 11.55% | 8.03% | 0.60% | -4.50% | -3.81% |
| Treasury Stock & Other | 33.65% | 41.78% | 12.29% | 13.53% | -39.01% |
| Total Common Equity | 831.59% | 1,076.33% | 622.92% | 8,270.56% | 152.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 831.59% | 1,076.33% | 622.92% | 8,270.56% | 152.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 831.59% | 1,076.33% | 622.92% | 8,270.56% | 152.64% |
|
|
|||||